Success Metrics

Clinical Success Rate
94.7%

Based on 18 completed trials

Completion Rate
95%(18/19)
Active Trials
10(23%)
Results Posted
17%(3 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_2
3
7%
Ph not_applicable
21
49%
Ph phase_3
2
5%
Ph phase_4
3
7%

Phase Distribution

0

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution29 total trials
Phase 2Efficacy & side effects
3(10.3%)
Phase 3Large-scale testing
2(6.9%)
Phase 4Post-market surveillance
3(10.3%)
N/ANon-phased studies
21(72.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

18 of 21 finished

Non-Completion Rate

14.3%

3 ended early

Currently Active

10

trials recruiting

Total Trials

43

all time

Status Distribution
Active(13)
Completed(18)
Terminated(3)
Other(9)

Detailed Status

Completed18
unknown9
Recruiting7
Active, not recruiting3
Enrolling by invitation2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
43
Active
10
Success Rate
94.7%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (10.3%)
Phase 32 (6.9%)
Phase 43 (10.3%)
N/A21 (72.4%)

Trials by Status

active_not_recruiting37%
unknown921%
not_yet_recruiting12%
terminated12%
enrolling_by_invitation25%
recruiting716%
completed1842%
withdrawn25%

Recent Activity

Clinical Trials (43)

Showing 20 of 43 trialsScroll for more
NCT07288034Phase 2

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

Recruiting
NCT06917326Not Applicable

Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates

Completed
NCT06279013Not Applicable

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Recruiting
NCT05023967Phase 2

Metformin and Nightly Fasting in Women With Early Breast Cancer

Active Not Recruiting
NCT07095140Not Applicable

Studying the Effects of Nicotine Concentration and Flavor on Alcohol Use in Young Adults

Recruiting
NCT05282225Not Applicable

Adaptive Intervention for Adolescents Following Inpatient Psychiatric Care

Active Not Recruiting
NCT07091864Not Applicable

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

Recruiting
NCT07138326

Impact on the Absorption of Drugs in Ostomy Patients

Recruiting
NCT07024459Not Applicable

CARESCAPE Monitoring Systems ME Study

Enrolling By Invitation
NCT05838430Phase 4

Solriamfetol and CBT-I in Patients With Insomnia Disorder

Active Not Recruiting
NCT05110924Not Applicable

RCT Treatment Versus Non Treatment of Low-risk BCCs in Elderly

Terminated
NCT06530472

The Relationship Between Belief, Expectation, and Adherence to Therapy During COVID-19 Pandemic

Enrolling By Invitation
NCT06510985Not Applicable

Transcutaneous Vagus Nerve Stimulation (tVNS) for Improved Recovery After Exertion.

Not Yet Recruiting
NCT06404151

Comparison of Oxygen Reserve Index and Regional Cerebral Oxygen Saturation Indetermining Hypoxia in Obese Patients

Recruiting
NCT05480748

Oxygen Reserve Index Predicting Hypoxemia

Completed
NCT05641389

Improving Remote Breathalyzer Procedures Used by Clinicians and Researchers to Remotely Monitor Alcohol Use

Recruiting
NCT04539509Not Applicable

Post-Concussion Aerobic Exercise

Withdrawn
NCT06000436Not Applicable

Cardiovascular Disease Risk of Awareness

Unknown
NCT06050954Phase 2

A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA)

Withdrawn
NCT05842759Not Applicable

Avoiding Postinduction Hypotension: the Clinical ZERO-HYPOTENSION Proof-of-concept Study

Completed

Drug Details

Intervention Type
OTHER
Total Trials
43